King was previously CEO of Viant Medical, leading what Vantedge described as “a complete transformation of a focused, niche $220 million organization into a leading $1 million global services provider to the medical industry with 24 locations and more than 6,000 employees.”
Before Viant, King’s career included more than a decade at Covidien, ultimately serving as group president of emerging markets. Vantedge said King’s division was responsible for nearly 60% of Covidien’s growth and generated more than $2 billion of sales with more than 4,500 employees.
And before he joined the medtech industry, King flew aircra…